「Low RAI2 expression is a marker of poor prognosis in breast cancer<Abstract of dissertation>」の関連論文
-
PBK expression predicts favorable survival in colorectal cancer patients
-
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients
-
FE65 in breast cancer: its clinicopathological and biological significance
-
MDM4 as a prognostic factor for patients with gastric cancer with low expression of p53:immunohistochemical study of p53, MDM2, and MDM4
-
外科的に切除された膵癌におけるST2発現の臨床病理学的及び予後との関連性の検討
-
Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis
-
Relationship of Mitochondrial-Related Protein Expression with the Differentiation, Metastasis, and Poor Prognosis of Oral Squamous Cell Carcinoma
-
Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer
-
TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma
-
TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma
-
Effect of Radiotherapy after Breast-conserving Surgery in Elderly Patients with Early Breast Cancer according to the American Joint Committee on Cancer 8th Edition Breast Cancer Staging System in Japan
-
MYC Upregulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
-
DDIT4 Facilitates Lymph Node Metastasis via the Activation of NF-κB Pathway and Epithelial-Mesenchymal Transition
-
Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients
-
TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer
-
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma
-
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
-
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
-
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
-
Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer
-
Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma
-
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
-
Neutrophil–lymphocyte Ratio and Histological Response Correlate With Prognosis of Gastric Cancer Undergoing Neoadjuvant Chemotherapy
-
Intensity-modulated radiation therapy for lymph node oligo-recurrence
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer,a retrospective study
-
The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
ヒト肺腺癌細胞A549におけるエンドセリン-2欠失による抗がん効果
-
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
-
Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
-
Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival.
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
The Combination of Prognostic Nutritional Indicator and Serum Carcinoembryonic Antigen is Useful in Predicting Postoperative Recurrence in Stage II Colorectal Cancer
-
Neutrophil/lymphocyte ratio as a predictor of lymph node metastasis in extramammary Paget disease: A retrospective study
-
SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma
-
SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma
-
Clinical and Basic Research for Ovarian Cancer
-
Progesterone Receptor isoform B exerts inhibitory effects on tumor cell proliferation regulated by let-7b in Progesterone receptor-positive non-small cell lung cancer
-
Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer
-
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma (本文)
-
Elucidation of the role of αB-crystallin in malignant breast cancer
-
The Elevation in Preoperative Procalcitonin Is Associated with a Poor Prognosis for Patients Undergoing Resection for Colorectal Cancer.
-
Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3–MAML2 fusions in salivary gland mucoepidermoid carcinoma
-
Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression
-
Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression